Publications
- Comment to study: A randomized phase |III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild type (WT) KRAS metastatic colorectal cancer (mCRC) patients: German study AIO KRK-0306(FIRE-3)2013 | First Faculty of Medicine
- The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms2022 | First Faculty of Medicine
- Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study2021 | First Faculty of Medicine
- Expression of molecules of the Wnt pathway and of E-cadherin in the etiopathogenesis of human thymomas2020 | First Faculty of Medicine, Second Faculty of Medicine
- Peptid-receptor radionuklidová terapie v České republice2020 | First Faculty of Medicine, Second Faculty of Medicine
- Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors2020 | First Faculty of Medicine
- Onemocnění slinivky břišní2019 | First Faculty of Medicine, Second Faculty of Medicine
- Neuroendokrinní nádory pankreatu2019 | First Faculty of Medicine
- Pneumooncology in case reports - successes and controversies in thoracic oncology2018 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Oncology in a nutshell2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
Loading network view...